Literature DB >> 15946744

Frequent respiratory tract infections in the canine model of X-linked ectodermal dysplasia are not caused by an immune deficiency.

Margret L Casal1, Elizabeth A Mauldin, Sara Ryan, Jennifer L Scheidt, Jeffrey Kennedy, Peter F Moore, Peter J Felsburg.   

Abstract

As in many human patients with X-linked hypohidrotic ectodermal dysplasia (XHED), XHED dogs are at an increased risk for pulmonary disorders. Localized immune system defects had been suspected previously in affected dogs because of frequent infections and unexpected deaths due to opportunistic respiratory tract infections. Experiments were designed to examine systemic and localized humoral and cellular responses, development and function of T cells, and thymic morphology. All dogs used in these experiments were clinically healthy at the time of examination and their immune responses were compared to normal littermates. Serum immunoglobulin concentrations differed somewhat between normal dogs and dogs affected with XHED but they were all within normal ranges. The XHED dogs responded appropriately to vaccination with tetanus toxoid suggesting normal systemic B and plasma cell function. Thymic morphology was compared between normal and affected dogs and T cells were assessed for functionality. Numbers and phenotypes of T and B cells in blood and thymus of affected dogs were within normal limits suggesting normal development of T cells. Cytotoxic and phagocytic ability of macrophages and neutrophils was also normal in affected dogs. In contrast, the secretory IgA concentrations found in affected dogs were significantly higher than in normal dogs, while lacrimal secretions were significantly decreased. These results suggest a compensatory mechanism for secretory IgA, so that the total amount equals that in normal dogs. The results presented in this study indicate that the XHED dogs have a relatively intact immune system and suggest that the same is true for humans with the homologous form of XHED.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15946744      PMCID: PMC3327478          DOI: 10.1016/j.vetimm.2005.04.005

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  21 in total

1.  Clinical spectrum of anhidrotic ectodermal dysplasia.

Authors:  W B Reed; D A Lopez; B Landing
Journal:  Arch Dermatol       Date:  1970-08

2.  Anhidrotic ectodermal dysplasia: predisposition to bronchial disease.

Authors:  J O Beahrs; G A Lillington; R C Rosan; L Russin; J A Lindgren; P T Rowley
Journal:  Ann Intern Med       Date:  1971-01       Impact factor: 25.391

3.  Partial deletion of the bovine ED1 gene causes anhidrotic ectodermal dysplasia in cattle.

Authors:  C Drögemüller; O Distl; T Leeb
Journal:  Genome Res       Date:  2001-10       Impact factor: 9.043

Review 4.  Clinical and genetic aspects of X-linked ectodermal dysplasia in the dog -- a review including three new spontaneous cases.

Authors:  Enio Moura; Silvana M Cirio
Journal:  Vet Dermatol       Date:  2004-10       Impact factor: 1.589

5.  Transplantation of X-linked severe combined immunodeficient dogs with CD34+ bone marrow cells.

Authors:  Brian J Hartnett; DaPeng Yao; Steven E Suter; N Matthew Ellinwood; Paula S Henthorn; Peter E Moore; Peter A McSweeney; Richard A Nash; Jeffrey D Brown; Kenneth I Weinberg; Peter J Felsburg
Journal:  Biol Blood Marrow Transplant       Date:  2002       Impact factor: 5.742

6.  A single point mutation within the ED1 gene disrupts correct splicing at two different splice sites and leads to anhidrotic ectodermal dysplasia in cattle.

Authors:  Cord Drögemüller; Martin Peters; Joachim Pohlenz; Ottmar Distl; Tosso Leeb
Journal:  J Mol Med (Berl)       Date:  2002-02-20       Impact factor: 4.599

7.  Two-amino acid molecular switch in an epithelial morphogen that regulates binding to two distinct receptors.

Authors:  M Yan; L C Wang; S G Hymowitz; S Schilbach; J Lee; A Goddard; A M de Vos; W Q Gao; V M Dixit
Journal:  Science       Date:  2000-10-20       Impact factor: 47.728

8.  Salivary gland function in persons with ectodermal dysplasias.

Authors:  Hilde Nordgarden; Kari Storhaug; Staale Petter Lyngstadaas; Janicke Liaaen Jensen
Journal:  Eur J Oral Sci       Date:  2003-10       Impact factor: 2.612

9.  Expression of X-linked hypohidrotic ectodermal dysplasia in six males and in their mothers.

Authors:  A L Söderholm; I Kaitila
Journal:  Clin Genet       Date:  1985-08       Impact factor: 4.438

Review 10.  X-linked anhidrotic ectodermal dysplasia (ED1) in men, mice, and cattle.

Authors:  Cord Drögemüller; Ottmar Distl; Tosso Leeb
Journal:  Genet Sel Evol       Date:  2003       Impact factor: 4.297

View more
  10 in total

1.  Prenatal Treatment of X-Linked Hypohidrotic Ectodermal Dysplasia using Recombinant Ectodysplasin in a Canine Model.

Authors:  Carol A Margolis; Pascal Schneider; Kenneth Huttner; Neil Kirby; Timothy P Houser; Lee Wildman; Gary L Grove; Holm Schneider; Margret L Casal
Journal:  J Pharmacol Exp Ther       Date:  2019-04-18       Impact factor: 4.030

2.  Significant correction of disease after postnatal administration of recombinant ectodysplasin A in canine X-linked ectodermal dysplasia.

Authors:  Margret L Casal; John R Lewis; Elizabeth A Mauldin; Aubry Tardivel; Karine Ingold; Manuel Favre; Fabrice Paradies; Stephane Demotz; Olivier Gaide; Pascal Schneider
Journal:  Am J Hum Genet       Date:  2007-09-18       Impact factor: 11.025

3.  Neonatal treatment with recombinant ectodysplasin prevents respiratory disease in dogs with X-linked ectodermal dysplasia.

Authors:  Elizabeth A Mauldin; Olivier Gaide; Pascal Schneider; Margret L Casal
Journal:  Am J Med Genet A       Date:  2009-09       Impact factor: 2.802

4.  Early respiratory and ocular involvement in X-linked hypohidrotic ectodermal dysplasia.

Authors:  Jasna Dietz; Thomas Kaercher; Anne-Theres Schneider; Theodor Zimmermann; Kenneth Huttner; Ramsey Johnson; Holm Schneider
Journal:  Eur J Pediatr       Date:  2013-04-04       Impact factor: 3.183

5.  Ectodysplasin A regulates epithelial barrier function through sonic hedgehog signalling pathway.

Authors:  Sanming Li; Jing Zhou; Liying Zhang; Juan Li; Jingwen Yu; Ke Ning; Yangluowa Qu; Hui He; Yongxiong Chen; Peter S Reinach; Chia-Yang Liu; Zuguo Liu; Wei Li
Journal:  J Cell Mol Med       Date:  2017-08-07       Impact factor: 5.310

Review 6.  Canine and Feline Models of Human Genetic Diseases and Their Contributions to Advancing Clinical Therapies
.

Authors:  Brittney L Gurda; Allison M Bradbury; Charles H Vite
Journal:  Yale J Biol Med       Date:  2017-09-25

7.  Ectodysplasin signalling deficiency in mouse models of hypohidrotic ectodermal dysplasia leads to middle ear and nasal pathology.

Authors:  Ali Azar; Chiara Piccinelli; Helen Brown; Denis Headon; Michael Cheeseman
Journal:  Hum Mol Genet       Date:  2016-07-04       Impact factor: 6.150

8.  Lack of airway submucosal glands impairs respiratory host defenses.

Authors:  Lynda S Ostedgaard; Margaret P Price; Kristin M Whitworth; Mahmoud H Abou Alaiwa; Anthony J Fischer; Akshaya Warrier; Melissa Samuel; Lee D Spate; Patrick D Allen; Brieanna M Hilkin; Guillermo S Romano Ibarra; Miguel E Ortiz Bezara; Brian J Goodell; Steven E Mather; Linda S Powers; Mallory R Stroik; Nicholas D Gansemer; Camilla E Hippee; Keyan Zarei; J Adam Goeken; Thomas R Businga; Eric A Hoffman; David K Meyerholz; Randall S Prather; David A Stoltz; Michael J Welsh
Journal:  Elife       Date:  2020-10-07       Impact factor: 8.140

9.  X-Linked Hypohidrotic Ectodermal Dysplasia in Crossbred Beef Cattle Due to a Large Deletion in EDA.

Authors:  Donal O'Toole; Irene M Häfliger; Fabienne Leuthard; Brant Schumaker; Lynn Steadman; Brian Murphy; Cord Drögemüller; Tosso Leeb
Journal:  Animals (Basel)       Date:  2021-03-02       Impact factor: 2.752

10.  The EDA-deficient mouse has Zymbal's gland hypoplasia and acute otitis externa.

Authors:  Jorge Del-Pozo; Denis J Headon; James D Glover; Ali Azar; Sonia Schuepbach-Mallepell; Mahmood F Bhutta; Jon Riddell; Scott Maxwell; Elspeth Milne; Pascal Schneider; Michael Cheeseman
Journal:  Dis Model Mech       Date:  2022-03-30       Impact factor: 5.758

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.